Using triple radio-immunotherapy to overcome cancer immunotherapy resistance

Cancer Biol Med. 2023 Nov 16;20(11):788-794. doi: 10.20892/j.issn.2095-3941.2023.0268.

Authors

Zengfu Zhang^#¹, Xiaodong Zhang^#², Dawei Chen^{1

2}

Affiliations

¹ Department of Radiation Oncology, Shandong University Cancer Center, Jinan 250117, China.
² Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China.

^# Contributed equally.

PMID: 37975213
PMCID: PMC10690884
DOI: 10.20892/j.issn.2095-3941.2023.0268

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Combined Modality Therapy
Humans
Immunotherapy*
Neoplasms* / therapy

Grants and funding